What is Bausch + Lomb's pharmaceuticals — goodwill?

Bausch + Lomb (BLCO) reported pharmaceuticals — goodwill of $731M in Q1 2026.

How has Bausch + Lomb's pharmaceuticals — goodwill changed year-over-year?

Bausch + Lomb's pharmaceuticals — goodwill increased by 8.0% year-over-year, from $677M to $731M.

What does pharmaceuticals — goodwill mean?

Represents the intangible asset value recorded when the pharmaceutical segment is acquired for a price exceeding the fair market value of its identifiable net assets. This reflects the premium paid for brand reputation, customer relationships, and intellectual property within the ophthalmic pharmaceutical business.

Bausch + Lomb BLCO Pharmaceuticals — Goodwill

Other segment segments

Vision Care

$3.55B+0.4%

Surgical

$456M+28.5%

Similar metrics at other companies

BAXPharmaceuticals — Goodwill

$569M+2.2%

ATRPharma — Goodwill

$534.34M—

JNJPharmaceutical — Goodwill (Note 3)

$14.81B+35.8%

CAHPharmaceutical and Specialty Solutions — Goodwill

$9.67B+25.0%

JNJPharmaceutical — Goodwill, related to acquisitions

$0—

AMRXSpecialty — Goodwill

$366.31M0.0%

Other financials

Income statement

See full

Revenue$1.2B+9.4%

Operating income$33.0M+140%

Net income-$71.0M+66.5%

EPS (diluted)-$0.20+66.7%

Balance sheet

See full

Cash & equivalents$279.0M+29.8%

Total debt$5.0B+4.3%

Total equity$6.4B+0.3%

Total assets$13.8B+2.6%

Cash flow

See full

Operating cash flow$32.0M+228%

CapEx$100.0M-9.1%

Free cash flow-$68.0M+49.6%

Valuation

See full

Market cap$5.3B+10.2%

Profitability

See full

Operating margin4.4%+2.9pp

Net margin-4.2%-1.3pp

FCF margin-3.4%0.0pp

Returns & leverage

See full

Return on equity-3.4%-0.9pp

Debt / equity0.8×0.0×

Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Bausch + Lomb’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch + Lomb's pharmaceuticals — goodwill.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bausch + Lomb's pharmaceuticals — goodwill?: Bausch + Lomb (BLCO) reported pharmaceuticals — goodwill of $731M in Q1 2026.
How has Bausch + Lomb's pharmaceuticals — goodwill changed year-over-year?: Bausch + Lomb's pharmaceuticals — goodwill increased by 8.0% year-over-year, from $677M to $731M.
What does pharmaceuticals — goodwill mean?: Represents the intangible asset value recorded when the pharmaceutical segment is acquired for a price exceeding the fair market value of its identifiable net assets. This reflects the premium paid for brand reputation, customer relationships, and intellectual property within the ophthalmic pharmaceutical business.